## Most Common Drug Cause of SJS/TEN **Key Point:** Antibiotics account for approximately 30–50% of all drug-induced SJS/TEN cases globally, with sulfonamides and beta-lactams being the leading agents [cite:Robbins 10e Ch 25]. ### Epidemiology of Drug-Induced SJS/TEN | Drug Class | Frequency | Notable Agents | |---|---|---| | **Antibiotics** | 30–50% | Sulfonamides, amoxicillin, cephalosporins, fluoroquinolones | | Anticonvulsants | 15–20% | Phenytoin, carbamazepine, phenobarbital | | Antiretrovirals | 5–10% | Nevirapine, abacavir | | NSAIDs | 5–10% | Naproxen, ibuprofen, meloxicam | | Allopurinol | 2–5% | Especially in renal impairment | **High-Yield:** In India and other developing countries, sulfonamides (especially TMP-SMX) and beta-lactams remain the most frequent triggers because of their widespread use in primary care and infectious disease management [cite:Park 26e Ch 22]. ### Pathomechanism Drug-induced SJS/TEN occurs via: 1. Hapten formation: drug metabolites bind to keratinocytes 2. T-cell activation: CD8+ cytotoxic T cells recognize drug-peptide complex 3. Massive keratinocyte apoptosis: TNF-α, FasL, and perforin-mediated cell death 4. Epidermal-dermal separation: full-thickness necrosis in TEN **Clinical Pearl:** The temporal relationship is critical—SJS/TEN typically develops 1–8 weeks after drug initiation, though re-exposure can trigger reaction within 24–48 hours. ### Risk Factors for Severe Reaction - Genetic predisposition (HLA-B*1502 in carbamazepine; HLA-B*5801 in allopurinol) - Renal/hepatic impairment (delayed drug clearance) - Immunosuppression (HIV, malignancy) - Polypharmacy (multiple culprit drugs possible) **Warning:** Do not attribute all SJS/TEN to anticonvulsants or antiretrovirals—antibiotics are statistically more common and should be the first consideration in a drug-induced case.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.